OTCMKTS:ROHIQ - Rotech Healthcare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market Capitalization$169,100.00
P/E RatioN/A
Dividend YieldN/A
Beta-0.02
Rotech Healthcare Inc. is a provider of home medical equipment and related products and services in the United States. The Company offers oxygen, other respiratory therapy and durable home medical equipment and related services. The Company provides equipment and services in 48 states through approximately 425 operating locations located primarily in non-urban markets. It provides its equipment and services principally to older patients with breathing disorders, associated with chronic obstructive pulmonary diseases (COPD), which include chronic bronchitis and emphysema. In December 2011, the Company announced the acquisition of three home medical entities. The acquired businesses include Best Care HHC Acquisition Company LLC, NeighborCare Home Medical Equipment of Maryland, LLC and NeighborCare Home Medical Equipment, LLC.

Receive ROHIQ News and Ratings via Email

Sign-up to receive the latest news and ratings for ROHIQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:ROHIQ
CUSIPN/A
Phone+1-407-8224600

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$169,100.00

Rotech Healthcare (OTCMKTS:ROHIQ) Frequently Asked Questions

What is Rotech Healthcare's stock symbol?

Rotech Healthcare trades on the OTCMKTS under the ticker symbol "ROHIQ."

Has Rotech Healthcare been receiving favorable news coverage?

Press coverage about ROHIQ stock has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Rotech Healthcare earned a news impact score of 0.16 on Accern's scale. They also assigned press coverage about the healthcare company an impact score of 46.55 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term. View Recent Headlines for Rotech Healthcare.

How do I buy shares of Rotech Healthcare?

Shares of ROHIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is Rotech Healthcare?

Rotech Healthcare has a market capitalization of $169,100.00.

How can I contact Rotech Healthcare?

Rotech Healthcare's mailing address is 2600 Technology Dr Ste 300, ORLANDO, FL 32804-8022, United States. The healthcare company can be reached via phone at +1-407-8224600.


MarketBeat Community Rating for Rotech Healthcare (OTCMKTS ROHIQ)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  80
MarketBeat's community ratings are surveys of what our community members think about Rotech Healthcare and other stocks. Vote "Outperform" if you believe ROHIQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ROHIQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Featured Article: What is the NASDAQ?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.